$146 Million is the total value of CAXTON CORP's 63 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 11.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SBBP | STRONGBRIDGE BIOPHARMA PLC | $24,008,000 | +7.6% | 8,083,442 | 0.0% | 16.45% | +13.5% | |
MTEM | Buy | MOLECULAR TEMPLATES INC | $16,719,000 | -37.6% | 2,137,991 | +0.7% | 11.46% | -34.2% |
CRDF | Buy | CARDIFF ONCOLOGY INC | $15,583,000 | -20.4% | 2,343,333 | +10.8% | 10.68% | -16.1% |
SCYX | Buy | SCYNEXIS INC | $10,956,000 | -2.0% | 1,488,623 | +5.7% | 7.51% | +3.4% |
SVRA | Buy | SAVARA INC | $10,117,000 | -15.4% | 5,951,015 | +3.5% | 6.93% | -10.8% |
KALA | Buy | KALA PHARMACEUTICALS INC | $9,036,000 | -6.2% | 1,704,849 | +19.2% | 6.19% | -1.1% |
SRRA | SIERRA ONCOLOGY INC | $8,645,000 | +13.0% | 443,959 | 0.0% | 5.92% | +19.2% | |
GLD | SPDR GOLD TR | $6,761,000 | +3.5% | 40,820 | 0.0% | 4.63% | +9.2% | |
RZLT | REZOLUTE INC | $6,054,000 | +102.1% | 424,243 | 0.0% | 4.15% | +113.3% | |
CTIC | Sell | CTI BIOPHARMA CORP | $5,786,000 | -20.9% | 2,314,533 | -8.0% | 3.96% | -16.6% |
ADXN | ADDEX THERAPEUTICS LTDsponsored ads | $2,542,000 | -9.0% | 265,940 | 0.0% | 1.74% | -4.0% | |
LUXA | LUX HEALTH TECH ACQUISITION | $1,978,000 | -3.7% | 200,000 | 0.0% | 1.36% | +1.6% | |
AACU | Sell | ARES ACQUISITION CORPORATIONunit 99/99/9999 | $1,397,000 | -1.6% | 139,680 | -1.6% | 0.96% | +3.8% |
ISEE | Buy | IVERIC BIO INC | $1,284,000 | +40.9% | 203,414 | +38.0% | 0.88% | +48.6% |
EIGR | Buy | EIGER BIOPHARMACEUTICALS INC | $1,181,000 | +41.8% | 138,626 | +47.3% | 0.81% | +49.5% |
GOOG | Buy | ALPHABET INCcap stk cl c | $933,000 | +110.1% | 372 | +73.8% | 0.64% | +121.9% |
INTU | Buy | INTUIT | $924,000 | +123.2% | 1,885 | +74.5% | 0.63% | +135.3% |
FB | Buy | FACEBOOK INCcl a | $892,000 | +105.5% | 2,566 | +74.0% | 0.61% | +116.7% |
PYPL | Buy | PAYPAL HLDGS INC | $892,000 | +108.9% | 3,060 | +74.2% | 0.61% | +120.6% |
CVNA | Buy | CARVANA COcl a | $872,000 | +100.0% | 2,888 | +74.0% | 0.60% | +111.0% |
CDLX | Buy | CARDLYTICS INC | $864,000 | +107.7% | 6,805 | +79.4% | 0.59% | +119.3% |
MCO | Buy | MOODYS CORP | $863,000 | +112.0% | 2,382 | +74.9% | 0.59% | +123.9% |
SPGI | Buy | S&P GLOBAL INC | $851,000 | +103.1% | 2,073 | +74.3% | 0.58% | +114.3% |
MSFT | Buy | MICROSOFT CORP | $829,000 | +100.7% | 3,059 | +74.7% | 0.57% | +111.9% |
V | Buy | VISA INC | $822,000 | +92.5% | 3,516 | +74.2% | 0.56% | +103.2% |
TDG | Buy | TRANSDIGM GROUP INC | $802,000 | +92.3% | 1,239 | +74.5% | 0.55% | +102.6% |
MA | Buy | MASTERCARD INCORPORATEDcl a | $798,000 | +77.7% | 2,185 | +73.4% | 0.55% | +87.3% |
AMT | Buy | AMERICAN TOWER CORP NEW | $782,000 | +98.5% | 2,896 | +75.7% | 0.54% | +109.4% |
DIS | Buy | DISNEY WALT CO | $773,000 | +64.8% | 4,400 | +73.0% | 0.53% | +73.8% |
CHTR | Buy | CHARTER COMMUNICATIONS INC Ncl a | $766,000 | +105.4% | 1,062 | +75.8% | 0.52% | +116.9% |
WHR | Buy | WHIRLPOOL CORP | $761,000 | +71.8% | 3,490 | +73.8% | 0.52% | +80.9% |
MDLZ | Buy | MONDELEZ INTL INCcl a | $752,000 | +86.6% | 12,046 | +75.1% | 0.52% | +96.6% |
FICO | Buy | FAIR ISAAC CORP | $747,000 | +80.4% | 1,486 | +74.6% | 0.51% | +90.3% |
CRM | Buy | SALESFORCE COM INC | $730,000 | +103.9% | 2,988 | +76.8% | 0.50% | +114.6% |
NFLX | Buy | NETFLIX INC | $697,000 | +77.8% | 1,319 | +75.4% | 0.48% | +87.5% |
BTWN | BRIDGETOWN HOLDINGS LTD | $634,000 | -6.8% | 62,688 | 0.0% | 0.43% | -1.8% | |
FLAC | FRAZIER LIFESCIENCES ACQU CO | $625,000 | -1.9% | 64,000 | 0.0% | 0.43% | +3.4% | |
SSAAU | SCIENCE STRATEGIC ACQ ALPHAunit 01/20/2026 | $616,000 | 0.0% | 62,000 | 0.0% | 0.42% | +5.5% | |
HMCOU | Sell | HUMANCO ACQUISITION CORPunit 12/08/2023 | $598,000 | -33.7% | 57,724 | -32.5% | 0.41% | -30.0% |
ELEV | New | ELEVATION ONCOLOGY INC | $537,000 | – | 39,586 | +100.0% | 0.37% | – |
AJAX | Sell | AJAX I | $498,000 | -55.1% | 50,000 | -53.7% | 0.34% | -52.6% |
GIGGU | GIGCAPITAL4 INCunit 99/99/9999 | $460,000 | +3.6% | 45,000 | 0.0% | 0.32% | +9.4% | |
ONCS | Buy | ONCOSEC MED INC | $449,000 | -18.8% | 159,935 | +38.0% | 0.31% | -14.2% |
SWBKU | SWITCHBACK II CORPORATIONunit 99/99/9999 | $395,000 | -0.5% | 39,000 | 0.0% | 0.27% | +5.0% | |
BOASU | BOA ACQUISITION CORPunit 99/99/9999 | $338,000 | 0.0% | 34,070 | 0.0% | 0.23% | +5.5% | |
SVFA | SVF INVESTMENT CORP | $276,000 | -3.2% | 27,900 | 0.0% | 0.19% | +2.2% | |
ISOSU | ISOS ACQUISITION CORPORATIONunit 99/99/9999 | $245,000 | +2.5% | 24,000 | 0.0% | 0.17% | +8.4% | |
PV | PRIMAVERA CAPITAL ACQUIST CO | $234,000 | -0.4% | 24,000 | 0.0% | 0.16% | +4.6% | |
SCOAU | Sell | SCION TECH GROWTH Iunit 12/17/2025 | $227,000 | -61.4% | 22,410 | -61.7% | 0.16% | -59.2% |
PICCU | PIVOTAL INVESTMENT CORP IIIunit 01/28/2028 | $168,000 | 0.0% | 16,800 | 0.0% | 0.12% | +5.5% | |
HLXA | HELIX ACQUISITION CORP | $165,000 | +1.2% | 16,009 | 0.0% | 0.11% | +6.6% | |
SRNGU | Sell | SOARING EAGLE ACQUISITION COunit 02/23/2026 | $159,000 | -56.3% | 15,000 | -58.3% | 0.11% | -53.8% |
ALDX | Sell | ALDEYRA THERAPEUTICS INC | $134,000 | -61.8% | 11,784 | -60.1% | 0.09% | -59.6% |
AJAXWS | AJAX I*w exp 10/27/202 | $117,000 | +10.4% | 62,500 | 0.0% | 0.08% | +15.9% | |
RTP | REINVENT TECHNOLOGY PARTNERScl a | $110,000 | -1.8% | 11,000 | 0.0% | 0.08% | +2.7% | |
NGAC | NEXTGEN ACQUISITION CORPcl a | $109,000 | 0.0% | 11,000 | 0.0% | 0.08% | +5.6% | |
RMGCU | RMG ACQUISITION CORP IIIunit 02/08/2026 | $110,000 | +0.9% | 11,000 | 0.0% | 0.08% | +5.6% | |
DGNR | DRAGONEER GROWTH OPPORTUN CO | $110,000 | -1.8% | 11,000 | 0.0% | 0.08% | +2.7% | |
LUXAW | LUX HEALTH TECH ACQUISITION*w exp 11/30/202 | $90,000 | -9.1% | 66,666 | 0.0% | 0.06% | -3.1% | |
BTWNW | BRIDGETOWN HOLDINGS LTD*w exp 09/30/202 | $83,000 | -28.4% | 39,773 | 0.0% | 0.06% | -24.0% | |
MRACW | Sell | MARQUEE RAINE ACQUISITION CO*w exp 12/01/202 | $29,000 | -12.1% | 23,171 | -12.1% | 0.02% | -4.8% |
FLACW | FRAZIER LIFESCIENCES ACQU CO*w exp 11/30/202 | $26,000 | +36.8% | 21,333 | 0.0% | 0.02% | +50.0% | |
PVWS | PRIMAVERA CAPITAL ACQUIST CO*w exp 01/19/202 | $13,000 | +30.0% | 12,000 | 0.0% | 0.01% | +50.0% | |
VGAC | Exit | VG ACQUISITION CORP | $0 | – | -11,000 | -100.0% | -0.07% | – |
SPRQ | Exit | SPARTAN ACQUISITION CORP II | $0 | – | -11,000 | -100.0% | -0.08% | – |
HEC | Exit | HUDSON EXECUTIVE INVT CORP | $0 | – | -25,000 | -100.0% | -0.16% | – |
FTOC | Exit | FTAC OLYMPUS ACQUISITION COR | $0 | – | -25,000 | -100.0% | -0.17% | – |
GMIIU | Exit | GORES METROPOULOS II INCunit 01/31/2028 | $0 | – | -32,000 | -100.0% | -0.21% | – |
PTMN | Exit | PORTMAN RIDGE FIN CORP | $0 | – | -293,144 | -100.0% | -0.41% | – |
MRAC | Exit | MARQUEE RAINE ACQUISITION CO | $0 | – | -105,500 | -100.0% | -0.68% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MOLECULAR TEMPLATES INC | 24 | Q2 2023 | 30.7% |
STRONGBRIDGE BIOPHARMA PLC | 22 | Q3 2021 | 73.1% |
GARRISON CAP INC | 18 | Q3 2020 | 9.9% |
BERKSHIRE HATHAWAY INC DEL | 17 | Q3 2019 | 5.8% |
EIGER BIOPHARMACEUTICALS INC | 17 | Q3 2022 | 1.7% |
AGILE THERAPEUTICS INC | 16 | Q1 2018 | 55.5% |
KALA PHARNACEUTICALS INC | 16 | Q4 2021 | 17.6% |
CM FIN INC | 16 | Q1 2019 | 7.8% |
SYNTA PHARMACEUTICALS CORP | 15 | Q2 2016 | 99.9% |
CTI BIOPHARMA CORP | 14 | Q4 2021 | 8.7% |
View CAXTON CORP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Addex Therapeutics Ltd. | February 14, 2023 | 718,849 | 0.9% |
Cardiff Oncology, Inc. | February 14, 2023 | 983,607 | 2.2% |
Rezolute, Inc. | February 14, 2023 | 1,860,518 | 5.0% |
Xeris Biopharma Holdings, Inc. | February 14, 2023 | 5,973,324 | 4.4% |
CTI BIOPHARMA CORP | February 14, 2022 | 2,239,300 | 2.3% |
Sierra Oncology, Inc. | February 14, 2022 | 1,119,322 | 7.0% |
Strongbridge Biopharma plcSold out | January 05, 2022 | 0 | 0.0% |
SUNESIS PHARMACEUTICALS INCSold out | February 16, 2021 | 0 | 0.0% |
Alcentra Capital Corp | February 14, 2020 | 1,005,000 | 7.8% |
Garrison Capital Inc. | February 14, 2020 | 1,223,096 | 7.6% |
View CAXTON CORP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G/A | 2023-02-14 |
SC 13G/A | 2023-02-14 |
SC 13G/A | 2023-02-14 |
SC 13G/A | 2023-02-14 |
View CAXTON CORP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.